3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
9
Prostatic Neoplasms, Castration-Resistant
6
Metastatic Castration-resistant Prostate Cancer
2
Pain
1
Neoplasms
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Fractures, Bone
1
Fatigue
1
Castration-resistant Prostate Cancer
1
Bony Metastases From Castrate Refractory Prostate Cancer
1
Bone Neoplasms
1
Bone Metastatic Castration-resistant Prostate Cancer
1
Advanced Prostate Cancer
1
Interventions
Surveys and Questionnaires
8
Psychiatric Rehabilitation
6
Fentanyl
4
Interviews as Topic
3
Therapeutics
2
Oxycodone
2
Mental Status and Dementia Tests
2
Analgesics, Opioid
2
ziprasidone
1
radium Ra 223 dichloride
1
pegfilgrastim
1
exemestane
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Urinary Catheterization
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Ropivacaine
1
Rocuronium
1
Restraint, Physical
1
Rehabilitation
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Quality of Life
1
Plastic Surgery Procedures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Pain
×
radium Ra 223 dichloride
×
Clear all
NCT03223597
2022-04-15
ROTOR
The Netherlands Cancer Institute
Completed
300 enrolled